Viloxazine is a selective norepinephrine reuptake inhibitor of the morpholine class, utilized primarily for the treatment of attention-deficit/hyperactivity disorder. This category provides an essential… Read more








































Viloxazine is a selective norepinephrine reuptake inhibitor of the morpholine class, utilized primarily for the treatment of attention-deficit/hyperactivity disorder. This category provides an essential collection of reference standards for Viloxazine, supporting rigorous analytical testing and quality control protocols in pharmaceutical laboratories. The selection includes high-quality active pharmaceutical ingredient (API) standards alongside a comprehensive range of pharmacopeial and non-pharmacopeial impurities, such as specific nitroso derivatives, hydroxy metabolites, and related degradation products. These materials are critical for impurity profiling and method validation, allowing researchers to accurately detect and quantify potential byproducts. Additionally, stable isotope labelled compounds are available to serve as internal standards for mass spectrometry-based assays, ensuring precise identification and reliable pharmacokinetic studies of the drug and its metabolic pathways throughout the development and manufacturing processes.